Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
125
datasets available to search
ShareScore release 0.9.0
Dataset results
125 results for “Relapsing-remitting multiple sclerosis”
Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)
ClinicalTrials.gov study NCT06663189. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New
ClinicalTrials.gov study NCT01110993. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT05366036. IPD Sharing: YES. Countries: 1. Publications: 0.
TMP001 in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02686788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01081782. IPD Sharing: Not stated. Countries: 11. Publications: 0.
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT03958877. IPD Sharing: YES. Countries: 22. Publications: 0.
A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT07321093. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02222948. IPD Sharing: Not stated. Countries: 5. Publications: 0.
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
ClinicalTrials.gov study NCT05758831. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses [Illumina]
GEO Series GSE130491. Homo sapiens. 82 samples. Type: Methylation profiling by genome tiling array.
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses
GEO Series GSE130494. Homo sapiens. 110 samples. Type: Expression profiling by array; Methylation profiling by genome tiling array.
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis is linked with monocytic oxidative responses [Affymetrix]
GEO Series GSE130478. Homo sapiens. 28 samples. Type: Expression profiling by array.
Glatiramer Acetate modulates ion channel expression and calcium homeostasis in B-cell of patients with relapsing-remitting multiple sclerosis
GEO Series GSE110023. Homo sapiens. 30 samples. Type: Expression profiling by array.
Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects
ClinicalTrials.gov study NCT00101959. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
ClinicalTrials.gov study NCT00239655. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate
ClinicalTrials.gov study NCT04925778. IPD Sharing: NO. Countries: 0. Publications: 0.
Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT02428218. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02753088. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT00292266. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00004814. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.